HANA AUBRECHTOVA: Open Payments
NPI 1831307289 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,950 in 117 payments from 27 companies in 2025. Trend: 2023 $3,886 · 2024 $3,389 · 2025 $2,950
Food & beverage: $2,950
| Company | Payments | Amount |
|---|---|---|
| LivaNova USA, Inc. | 12 | $720 |
| ABBVIE INC. | 20 | $342 |
| Novartis Pharmaceuticals Corporation | 14 | $298 |
| Biogen, Inc. | 12 | $269 |
| SK Life Science, Inc. | 6 | $154 |
| Genentech USA, Inc. | 8 | $145 |
| Teva Pharmaceuticals USA, Inc. | 4 | $130 |
| Lilly USA, LLC | 5 | $104 |
| TG Therapeutics, Inc. | 3 | $96 |
| PFIZER INC. | 5 | $93 |
Products named: VNS THERAPY SENTIVA MODEL 1000 GENERATOR, KESIMPTA, LEQEMBI, Ocrevus Zunovo, AJOVY, AMYVID, UBRELVY, BRIUMVI.
Industry payments across TX — which companies pay providers there.
